Heron Therapeutics, Inc. (HRTX)
NASDAQ: HRTX · IEX Real-Time Price · USD
2.740
-0.730 (-21.04%)
At close: Jul 2, 2024, 4:00 PM
2.890
+0.150 (5.47%)
After-hours: Jul 2, 2024, 7:37 PM EDT
Heron Therapeutics Market Cap
Heron Therapeutics has a market cap or net worth of $412.79 million as of July 2, 2024. Its market cap has increased by 184.88% in one year.
Market Cap
412.79M
Enterprise Value
520.44M
1-Year Change
184.88%
Ranking
Category
Stock Price
$2.74
Market Cap Chart
Since December 1, 1998, Heron Therapeutics's market cap has increased from $127.40M to $412.79M, an increase of 224.01%. That is a compound annual growth rate of 4.70%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 1, 2024 | 522.80M | 104.94% |
Dec 29, 2023 | 255.10M | -14.17% |
Dec 30, 2022 | 297.20M | -68.07% |
Dec 31, 2021 | 930.70M | -51.60% |
Dec 31, 2020 | 1.92B | -9.13% |
Dec 31, 2019 | 2.12B | 4.57% |
Dec 31, 2018 | 2.02B | 105.15% |
Dec 29, 2017 | 986.50M | 92.15% |
Dec 30, 2016 | 513.40M | -46.54% |
Dec 31, 2015 | 960.40M | 227.11% |
Dec 31, 2014 | 293.60M | 110.32% |
Dec 31, 2013 | 139.60M | -15.24% |
Dec 31, 2012 | 164.70M | 258.04% |
Dec 30, 2011 | 46.00M | 154.14% |
Dec 31, 2010 | 18.10M | -63.51% |
Dec 31, 2009 | 49.60M | 281.54% |
Dec 31, 2008 | 13.00M | -73.25% |
Dec 31, 2007 | 48.60M | 39.66% |
Dec 29, 2006 | 34.80M | -10.08% |
Dec 30, 2005 | 38.70M | -6.30% |
Dec 31, 2004 | 41.30M | -18.22% |
Dec 31, 2003 | 50.50M | 146.34% |
Dec 31, 2002 | 20.50M | -63.91% |
Dec 31, 2001 | 56.80M | 18.33% |
Dec 29, 2000 | 48.00M | -30.64% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Corbus Pharmaceuticals Holdings | 527.92M |
Third Harmonic Bio | 527.84M |
Neurogene | 527.26M |
Applied Therapeutics | 526.77M |
Larimar Therapeutics | 525.73M |
Y-mAbs Therapeutics | 519.13M |
ORIC Pharmaceuticals | 515.11M |
Lexeo Therapeutics | 514.28M |